Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. OMI
stocks logo

OMI

-
Add to WatchlistAdvanced Chart
$
0.000
0(0.000%)1D
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
2.73B
+2.26%
0.317
-12.01%
2.80B
+3.04%
0.465
+10.65%
2.82B
+4.47%
0.662
+20.33%
Estimates Revision
The market is revising Upward the revenue expectations for Owens & Minor, Inc. (OMI) for FY2025, with the revenue forecasts being adjusted by 0.23% over the past three months. During the same period, the stock price has changed by -15.65%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.23%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-5.96%
In Past 3 Month
Stock Price
Go Down
down Image
-15.65%
In Past 3 Month
4 Analyst Rating
up Image0
Wall Street analysts forecast OMI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OMI is 8.25 USD with a low forecast of 7.00 USD and a high forecast of 10.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
2 Sell
Moderate Sell
up Image0
Current: 6.900
sliders
Low
7.00
Averages
8.25
High
10.00
up Image0
Current: 6.900
sliders
Low
7.00
Averages
8.25
High
10.00
Baird
Eric Coldwell
Neutral
maintain
$9 -> $10
2025-06-06
Reason
Baird
Eric Coldwell
Price Target
$9 -> $10
2025-06-06
maintain
Neutral
Reason
Baird analyst Eric Coldwell raised the firm's price target on Owens & Minor to $10 from $9 and keeps a Neutral rating on the shares. The firm updated its model following the temrination of its Rotech deal.
BofA
Underperform
maintain
$7
2025-06-06
Reason
BofA
Price Target
$7
2025-06-06
maintain
Underperform
Reason
BofA raised the firm's price target on Owens & Minor to $7.50 from $7 and keeps an Underperform rating on the shares after the company announced that it and Rotech Healthcare have mutually agreed to terminate their pending merger. The news was "surprising" given the competitive landscape in the durable medical equipment space, says the firm, which did not view the combination of Owens & Minor and Rotech as anti-competitive. However, given the significant amount of time being allocated to this deal, the firm views the decision not to move forward favorably as it will allow the company to focus on its core operations, the analyst added. While the firm views the scrapped deal news positively, it thinks that a broader turnaround will require a "delicate balance" of reducing costs, improving working capital, and de-levering while investing for growth, BofA says.
Citigroup
Daniel Grosslight
Strong Buy
Maintains
$13 → $11
2025-04-17
Reason
Citigroup
Daniel Grosslight
Price Target
$13 → $11
2025-04-17
Maintains
Strong Buy
Reason
Citi lowered the firm's price target on Owens & Minor to $11 from $13 and keeps a Buy rating on the shares. The firm does not think the company's Q1 earnings will do much to assuage concerns around tariffs and the pending Rotech acquisition. Citi expects a relatively in-line quarter with no change to fiscal 2025 guidance.
JP Morgan
Michael Minchak
Sell
Maintains
$14 → $10
2025-03-10
Reason
JP Morgan
Michael Minchak
Price Target
$14 → $10
2025-03-10
Maintains
Sell
Reason
JPMorgan lowered the firm's price target on Owens & Minor to $10 from $14. The firm keeps an Underweight rating on the shares due to a "variety of moving parts" and continued uncertainty and improvement initiatives underway, the analyst tells investors in a research note. The firm notes continued challenges in demand and pricing for personal protective equipment as well as uncertainty around the ability to continue to offset headwinds on the cost side, and says that while Apria continues to drive performance in the Patient Direct business, broader reimbursement risk remains over the long-term and JPMorgan sees Rotech's acquisition as a swing factor.
Baird
Eric Coldwell
Hold
Maintains
$10 → $11
2025-03-03
Reason
Baird
Eric Coldwell
Price Target
$10 → $11
2025-03-03
Maintains
Hold
Reason
Baird lowered the firm's price target on Owens & Minor to $10 from $14 and keeps a Neutral rating on the shares. The firm is designating Owens & Minor as a bullish Fresh Pick.
UBS
Kevin Caliendo
Strong Buy
Maintains
$25 → $13
2025-02-13
Reason
UBS
Kevin Caliendo
Price Target
$25 → $13
2025-02-13
Maintains
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Owens & Minor Inc (OMI.N) is 3.88, compared to its 5-year average forward P/E of 10.76. For a more detailed relative valuation and DCF analysis to assess Owens & Minor Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
10.76
Current PE
3.88
Overvalued PE
14.39
Undervalued PE
7.13

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average EV/EBITDA
7.33
Current EV/EBITDA
4.73
Overvalued EV/EBITDA
8.98
Undervalued EV/EBITDA
5.69

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
0.18
Current PS
0.05
Overvalued PS
0.27
Undervalued PS
0.09

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

OMI News & Events

Events Timeline

(ET)
2025-06-05
12:00:53
Owens & Minor rises 16.8%
select
2025-06-05
10:00:27
Owens & Minor rises 17.1%
select
2025-06-05
09:47:28
Owens & Minor rises 14.3%
select
Sign Up For More Events
Sign Up For More Events

News

Preview
8.0
07-10NASDAQ.COM
Notable Wednesday Option Activity: OMI, AES, MO

  • AES Corp Options Activity: AES Corp has seen a high options trading volume of 82,892 contracts today, with significant activity in the $11.50 strike call option expiring July 11, 2025, totaling 8,571 contracts.

  • Altria Group Options Activity: Altria Group Inc reported an options trading volume of 41,528 contracts, particularly notable for the $55 strike put option expiring August 15, 2025, with 6,006 contracts traded.

Preview
8.5
06-06Yahoo Finance
Owens & Minor and Rotech Healthcare Agree to End Previously Planned Acquisition

  • Acquisition Cancellation: Owens & Minor, Inc. has mutually agreed with Rotech Healthcare to cancel their planned acquisition, resulting in an $80 million payment to Rotech and the redemption of $1 billion in notes due in 2025.

  • Future Strategy: Despite the setback, Owens & Minor's CEO expressed confidence in the company's strategy to expand its Patient Direct business while focusing on cash flow improvement and debt reduction, amidst ongoing discussions for potential sales of other business segments.

Preview
8.0
06-06NASDAQ.COM
Notable Thursday Option Activity: OMI, FTAI, DECK

  • FTAI Aviation Options Trading: FTAI Aviation Ltd experienced significant options trading with 5,215 contracts, particularly for the $145 strike call option expiring June 20, 2025, indicating strong interest in this stock.

  • Deckers Outdoor Options Trading: Deckers Outdoor Corp saw a high volume of 18,587 options contracts traded, notably for the $165 strike put option expiring June 20, 2025, reflecting substantial market activity.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Owens & Minor Inc (OMI) stock price today?

The current price of OMI is 6.9 USD — it has increased 5.02 % in the last trading day.

arrow icon

What is Owens & Minor Inc (OMI)'s business?

Owens & Minor, Inc. is a global healthcare solutions company providing essential products and services that support care from the hospital to the home. The Company operates through two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment includes its United States distribution division (Medical Distribution), including an outsourced logistics and value-added services business, and its Global Products division, which manufactures and sources medical surgical products through its production and kitting operations. It provides medical supplies and solutions for infection prevention across acute, alternate site and consumer channels. The Patient Direct segment includes its home healthcare divisions (Byram and Apria). The segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States.

arrow icon

What is the price predicton of OMI Stock?

Wall Street analysts forecast OMI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OMI is 8.25 USD with a low forecast of 7.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Owens & Minor Inc (OMI)'s revenue for the last quarter?

Owens & Minor Inc revenue for the last quarter amounts to 2.63B USD, increased 0.74 % YoY.

arrow icon

What is Owens & Minor Inc (OMI)'s earnings per share (EPS) for the last quarter?

Owens & Minor Inc. EPS for the last quarter amounts to -0.32 USD, increased 10.34 % YoY.

arrow icon

What changes have occurred in the market's expectations for Owens & Minor Inc (OMI)'s fundamentals?

The market is revising Upward the revenue expectations for Owens & Minor, Inc. (OMI) for FY2025, with the revenue forecasts being adjusted by 0.23% over the past three months. During the same period, the stock price has changed by -15.65%.
arrow icon

How many employees does Owens & Minor Inc (OMI). have?

Owens & Minor Inc (OMI) has 13500 emplpoyees as of August 05 2025.

arrow icon

What is Owens & Minor Inc (OMI) market cap?

Today OMI has the market capitalization of 528.64M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free